EXSCALATE4COV
- /
- Projects
- /
- Closed projects
- /
- EXSCALATE4COV
The EXSCALATE4CoV (E4C) project aims to exploit the most powerful computing resources currently based in Europe to empower smart in-silico drug design. Advanced Computer-Aided Drug Design (CADD) in combination with the high throughput biochemical and phenotypic screening will allow the rapid evaluation of the simulations results and the reduction of time for the discovery of new drugs. Against a pandemic crisis, the immediate identification of effective treatments have a paramount importance.
Call: RIA - H2020-EU.3.1.3. - Treating and managing disease
Start date: 01/04/2020
End date: 30/09/2021
External links: Follow the external link
Partners: 18 EU top organizations from 7 countries:DOMPE FARMACEUTICI SPA - Italy - COORDINATORCINECA CONSORZIO INTERUNIVERSITARIO - ItalyPOLITECNICO DI MILANO - ItalyUNIVERSITA DEGLI STUDI DI MILANO - ItalyKATHOLIEKE UNIVERSITEIT LEUVEN - BelgiumINTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY - PolandELETTRA - SINCROTRONE TRIESTE SCPA - ItalyFRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. - GermanyBARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION - SpainFORSCHUNGSZENTRUM JULICH GMBH - GermanyUNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II - ItalyUNIVERSITA DEGLI STUDI DI CAGLIARI - ItalySIB INSTITUT SUISSE DE BIOINFORMATIQUE - SwitzerlandKUNGLIGA TEKNISKA HOEGSKOLAN - SwedenISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-IRCCS - ItalyASSOCIAZIONE BIG DATA - ItalyISTITUTO NAZIONALE DI FISICA NUCLEARE - ItalyCHELONIA SA - Switzerland